Figure 1From: Continuing or adding IL-2 in patients treated with antiretroviral therapy (ACTG Protocol A5051, a rollover trial of ACTG Protocol A328)Median CD4 T cell counts over time for the participants in A5051. The 'Previous IL-2' group initiated IL-2 at week 12 of A328. The 'No prior IL-2' group initiated IL-2 in A5051. Vertical bars represent 25th and 75th percentiles.Back to article page